Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Tuesday, 8 August 2017

Rapha Strengthens Leadership Position and Growth Ambitions With Investment From RZC

 
Rapha Strengthens Leadership Position and Growth Ambitions With Investment From RZC
LONDON, August 8, 2017 /PRNewswire/ -- Cycling lifestyle brand Rapha is delighted to announce that US-based RZC Investments is now the majority shareholder in the business. Rapha has been owned since launch by Simon Mottram and a group of founder shareholders, including lead investor,...
Read more

Hemex Health Selects Tata Elxsi as the Product Design and Engineering Partner for its 'Lab-in-a-Box' -- a Point-of-care Diagnostic Platform
BANGALORE and PORTLAND , Oregon, August 8, 2017 /PRNewswire/ -- Hemex Health, an early stage medical diagnostics enterprise, announced the selection of Tata Elxsi as the product design and engineering partner of its latest Lab-in-a-Box diagnostic device.      (Logo: http:...
Read more

Wirecard and FinTech Firm Billie Launch New Online Factoring Solution
MUNICH, August 8, 2017 /PRNewswire/ -- - Billie offers online factoring for SMEs and freelancers  - Wirecard supports Billie in the digitisation of payment processing  Wirecard, the leading supplier of digital payment solutions and internet technology, will support the Berlin-...
Read more

Jungheinrich Raises Forecast for the 2017 Financial Year
HAMBURG, Germany, August 8, 2017 /PRNewswire/ -- First half-year: net sales +14 per cent, value of incoming orders +8 per cent and units +12 per cent  Orders on hand at the end of June: +16 per cent on the end of 2016  Forecast raised for incoming orders and net sales,...
Read more

Scottish Medicines Consortium Accepts Amgen's Multiple Myeloma Treatment, KYPROLIS® ▼ (carfilzomib), in Combination with Dexamethasone, for use at First Relapse
CAMBRIDGE, England, August 8, 2017 /PRNewswire/ -- Carfilzomib Accepted in Combination with Dexamethasone Alone for the Treatment of Adult Patients with Multiple Myeloma who have Received At least One Prior Therapy Patients Treated with Carfilzomib in Combination with...
Read more

Aegon to Sell Unirobe Meeùs Groep
THE HAGUE, the Netherlands, August 8, 2017 /PRNewswire/ -- Aegon has agreed to sell Unirobe Meeùs Groep (UMG), an independent financial advisory group, to Aon Groep Nederland for EUR 295 million. The transaction is consistent with Aegon's strategic objective to optimize its portfolio...
Read more

Aegon to Sell Unirobe Meeùs Groep
THE HAGUE, the Netherlands, August 8, 2017 /PRNewswire/ -- Aegon has agreed to sell Unirobe Meeùs Groep (UMG), an independent financial advisory group, to Aon Groep Nederland for EUR 295 million. The transaction is consistent with Aegon's strategic objective to optimize its portfolio...
Read more